Clinical Trial Update: Daridorexant for Alzheimer Disease Prevention [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of daridorexant for Alzheimer's disease prevention is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• QUVIVIQ (daridorexant)

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Alzheimer Disease (AD) | Phase 2 | Status: RECRUITING